Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
2024-10-03 Sale | 2024-10-07 07:55 am | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $54.63 | $785,306 | 167,549 (Direct) | View |
2024-09-26 Sale | 2024-09-30 5:01 pm | Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO | 25,000 | $51.11 | $1,277,750 | 200,092 (Direct) | View |
2024-09-10 Sale | 2024-09-12 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 1,035 | $51.5 | $53,303 | 68,576 (Direct) | View |
2024-08-26 Sale | 2024-08-28 4:31 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $53.19 | $159,570 | 69,611 (Direct) | View |
2024-08-12 Sale | 2024-08-14 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $47.68 | $143,040 | 72,611 (Direct) | View |
2024-07-25 Sale | 2024-07-26 4:38 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $53.43 | $160,290 | 75,611 (Direct) | View |
2024-07-25 Sale | 2024-07-26 4:24 pm | Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO | 19,056 | $53.88 | $1,026,737 | 111,092 (Direct) | View |
2024-07-15 Sale | 2024-07-17 5:35 pm | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 27,000 | $55 | $1,485,000 | 269,680 (Direct) | View |
2024-07-15 Sale | 2024-07-17 5:14 pm | Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO | 25,000 | $55 | $1,375,000 | 177,092 (Direct) | View |
2024-07-10 Sale | 2024-07-12 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $48.55 | $145,650 | 78,611 (Direct) | View |
2024-07-05 Sale | 2024-07-09 6:04 pm | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 15,000 | $44.08 | $661,200 | 159,259 (Direct) | View |
2024-07-03 Sale | 2024-07-05 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $44.87 | $645,006 | 181,924 (Direct) | View |
2024-06-28 Sale | 2024-07-02 4:32 pm | Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO | 32,129 | $43.61 | $1,401,146 | 130,148 (Direct) | View |
2024-06-26 Sale | 2024-06-28 5:31 pm | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 956 | $44.38 | $42,427 | 52,580 (Direct) | View |
2024-06-25 Sale | 2024-06-26 4:32 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $45.37 | $136,110 | 80,643 (Direct) | View |
2024-06-24 Sale | 2024-06-25 5:03 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 9,500 | $45.73 | $434,435 | 195,578 (Direct) | View |
2024-06-21 Sale | 2024-06-24 5:08 pm | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 15,000 | $44.66 | $669,900 | 174,259 (Direct) | View |
2024-06-10 Sale | 2024-06-11 4:35 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $43.86 | $131,580 | 83,643 (Direct) | View |
2024-05-28 Sale | 2024-05-30 4:28 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $47.49 | $142,470 | 86,643 (Direct) | View |
2024-05-10 Sale | 2024-05-14 6:29 pm | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,000 | $49.43 | $148,290 | 89,643 (Direct) | View |
2024-05-08 Sale | 2024-05-10 4:57 pm | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 107,448 | $49.4 | $5,307,931 | 1,175,632 (Indirect Direct) | View |
2024-04-15 Sale | 2024-04-17 4:36 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $44.47 | $639,256 | 205,078 (Direct) | View |
2024-04-04 Sale | 2024-04-08 5:09 pm | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 40,951 | $49.17 | $2,013,561 | 1,263,430 (Indirect Direct) | View |
2024-03-28 Sale | 2024-04-02 4:35 pm | Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director | 17,500 | $46.38 | $811,650 | 6,000 (Direct) | View |
2024-03-22 Sale | 2024-03-26 4:30 pm | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 32,359 | $44.31 | $1,433,675 | 182,580 (Direct) | View |
2024-03-20 Sale | 2024-03-22 4:52 pm | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 15,089 | $44.06 | $664,763 | 421,120 (Direct) | View |
2024-03-20 Sale | 2024-03-22 4:31 pm | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 60,000 | $44.14 | $2,648,150 | 18,536 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
2024-10-03 Exercise | 2024-10-07 07:55 am | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $0 | 167,549 (Direct) | View |
2024-10-03 Exercise | 2024-10-07 07:55 am | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $16.89 | 167,549 (Direct) | View |
2024-09-26 Exercise | 2024-09-30 5:01 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO | 25,000 | $15.29 | 200,092 (Direct) | View |
2024-09-26 Exercise | 2024-09-30 5:01 pm | N/A 2031-02-26 | Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO | 25,000 | $0 | 200,092 (Direct) | View |
2024-07-25 Exercise | 2024-07-26 4:24 pm | N/A 2028-05-24 | Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO | 19,056 | $0 | 111,092 (Direct) | View |
2024-07-25 Exercise | 2024-07-26 4:24 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO | 19,056 | $9.28 | 111,092 (Direct) | View |
2024-07-15 Exercise | 2024-07-17 5:35 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 17,499 | $23.98 | 269,680 (Direct) | View |
2024-07-15 Exercise | 2024-07-17 5:35 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 2,887 | $20.02 | 269,680 (Direct) | View |
2024-07-15 Exercise | 2024-07-17 5:35 pm | N/A 2031-09-01 | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 26,073 | $0 | 269,680 (Direct) | View |
2024-07-15 Exercise | 2024-07-17 5:35 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 5,687 | $19.64 | 269,680 (Direct) | View |
2024-07-15 Exercise | 2024-07-17 5:14 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO | 25,000 | $20.02 | 177,092 (Direct) | View |
2024-07-15 Exercise | 2024-07-17 5:14 pm | N/A 2032-02-29 | Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO | 25,000 | $0 | 177,092 (Direct) | View |
2024-07-05 Exercise | 2024-07-09 6:04 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 15,000 | $19.73 | 159,259 (Direct) | View |
2024-07-05 Exercise | 2024-07-09 6:04 pm | N/A 2032-03-10 | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 15,000 | $0 | 159,259 (Direct) | View |
2024-07-03 Exercise | 2024-07-05 4:30 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $0 | 181,924 (Direct) | View |
2024-07-03 Exercise | 2024-07-05 4:30 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $16.89 | 181,924 (Direct) | View |
2024-06-28 Exercise | 2024-07-02 4:32 pm | N/A 2028-05-24 | Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO | 32,129 | $0 | 130,148 (Direct) | View |
2024-06-28 Exercise | 2024-07-02 4:32 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Wilson Marc CFO | 32,129 | $9.28 | 130,148 (Direct) | View |
2024-06-24 Exercise | 2024-06-25 5:03 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 9,500 | $0 | 195,578 (Direct) | View |
2024-06-24 Exercise | 2024-06-25 5:03 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 9,500 | $16.89 | 195,578 (Direct) | View |
2024-06-21 Exercise | 2024-06-24 5:08 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 15,000 | $19.73 | 174,259 (Direct) | View |
2024-06-21 Exercise | 2024-06-24 5:08 pm | N/A 2032-03-10 | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 15,000 | $0 | 174,259 (Direct) | View |
2024-06-07 Option Award | 2024-06-11 4:21 pm | N/A 2034-06-07 | Crinetics Pharmaceuticals Inc. | CRNX | Deardorf Caren Director | 15,900 | $0 | 21,900 (Direct) | View |
2024-06-07 Option Award | 2024-06-11 4:21 pm | N/A 2034-06-07 | Crinetics Pharmaceuticals Inc. | CRNX | Vivaldi Coelho Rogerio Director | 15,900 | $0 | 26,900 (Direct) | View |
2024-06-07 Option Award | 2024-06-11 4:20 pm | N/A 2034-06-07 | Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director | 15,900 | $0 | 21,900 (Direct) | View |
2024-06-07 Option Award | 2024-06-11 4:20 pm | N/A 2034-06-07 | Crinetics Pharmaceuticals Inc. | CRNX | Nichols Weston Director | 15,900 | $0 | 21,900 (Direct) | View |
2024-06-07 Option Award | 2024-06-11 4:19 pm | N/A 2034-06-07 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 15,900 | $0 | 34,436 (Direct) | View |
2024-06-07 Option Award | 2024-06-11 4:19 pm | N/A 2034-06-07 | Crinetics Pharmaceuticals Inc. | CRNX | Bedrosian Camille L Director | 15,900 | $0 | 21,900 (Direct) | View |
2024-06-07 Option Award | 2024-06-11 4:18 pm | N/A 2034-06-07 | Crinetics Pharmaceuticals Inc. | CRNX | WIERENGA WENDALL Director | 15,900 | $0 | 121,746 (Direct) | View |
2024-05-08 Exercise | 2024-05-10 4:57 pm | N/A 2028-05-24 | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 107,448 | $0 | 1,175,632 (Direct) | View |
2024-05-08 Exercise | 2024-05-10 4:57 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 107,448 | $9.28 | 1,175,632 (Direct) | View |
2024-04-18 Gift | 2024-04-22 5:23 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 350 | $0 | 1,159,290 (Direct) | View |
2024-04-15 Exercise | 2024-04-17 4:36 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $0 | 205,078 (Direct) | View |
2024-04-15 Exercise | 2024-04-17 4:36 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $16.89 | 205,078 (Direct) | View |
2024-04-15 Exercise | 2024-04-17 4:30 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 20,000 | $1.91 | 1,240,910 (Direct) | View |
2024-04-15 Exercise | 2024-04-17 4:30 pm | N/A 2028-03-16 | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 20,000 | $0 | 1,240,910 (Direct) | View |
2024-04-04 Exercise | 2024-04-08 5:09 pm | N/A 2028-05-24 | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 40,951 | $0 | 1,263,430 (Direct) | View |
2024-04-04 Exercise | 2024-04-08 5:09 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Struthers Richard Scott President & CEO | 40,951 | $9.28 | 1,263,430 (Direct) | View |
2024-03-28 Exercise | 2024-04-02 4:35 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director | 17,500 | $18.29 | 6,000 (Direct) | View |
2024-03-28 Exercise | 2024-04-02 4:35 pm | N/A 2032-06-17 | Crinetics Pharmaceuticals Inc. | CRNX | Okey Stephanie Director | 17,500 | $0 | 6,000 (Direct) | View |
2024-03-22 Exercise | 2024-03-26 4:30 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 30,000 | $23.98 | 182,580 (Direct) | View |
2024-03-22 Exercise | 2024-03-26 4:30 pm | N/A 2031-09-01 | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 30,000 | $0 | 182,580 (Direct) | View |
2024-03-20 Exercise | 2024-03-22 4:52 pm | N/A 2032-10-10 | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $0 | 421,120 (Direct) | View |
2024-03-20 Exercise | 2024-03-22 4:52 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 14,375 | $16.89 | 421,120 (Direct) | View |
2024-03-20 Exercise | 2024-03-22 4:31 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 17,500 | $18.29 | 18,536 (Direct) | View |
2024-03-20 Exercise | 2024-03-22 4:31 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 17,500 | $20.23 | 18,536 (Direct) | View |
2024-03-20 Exercise | 2024-03-22 4:31 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 12,500 | $23.23 | 18,536 (Direct) | View |
2024-03-20 Exercise | 2024-03-22 4:31 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 12,500 | $23.24 | 18,536 (Direct) | View |
2024-03-20 Exercise | 2024-03-22 4:31 pm | N/A 2029-06-20 | Crinetics Pharmaceuticals Inc. | CRNX | Fust Matthew K Director | 60,000 | $0 | 18,536 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 6:36 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Pizzuti Dana Chief Med and Dev Officer | 411 | $38.14 | 28,500 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 6:35 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Knight Jeff E. Chief Operating Officer | 4,283 | $38.14 | 54,939 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 6:34 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Hassard James Chief Commercial Officer | 1,741 | $38.14 | 29,259 (Direct) | View |
2024-03-18 Tax Withholding | 2024-03-20 6:33 pm | N/A N/A | Crinetics Pharmaceuticals Inc. | CRNX | Betz Stephen F. Chief Scientific Officer | 3,655 | $38.14 | 92,643 (Direct) | View |